Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Angiography in Rectal Cancer Resection
NCT05263336Unknown
- Sponsor
- Jagiellonian University
- Start
- Jan 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of indocyanine green in rectal cancer (2 arms), sponsored by Jagiellonian University. Primary endpoint: Anastomotic leak at 2 weeks. Status: unknown.
02
Drugs
indocyanine green
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT05263336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05263336.